KR102276326B1 - 피부 회춘을 위한 펩타이드 및 이것을 사용하는 방법 - Google Patents

피부 회춘을 위한 펩타이드 및 이것을 사용하는 방법 Download PDF

Info

Publication number
KR102276326B1
KR102276326B1 KR1020157025086A KR20157025086A KR102276326B1 KR 102276326 B1 KR102276326 B1 KR 102276326B1 KR 1020157025086 A KR1020157025086 A KR 1020157025086A KR 20157025086 A KR20157025086 A KR 20157025086A KR 102276326 B1 KR102276326 B1 KR 102276326B1
Authority
KR
South Korea
Prior art keywords
skin
delete delete
collagen
composition
octanoylcarnosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157025086A
Other languages
English (en)
Korean (ko)
Other versions
KR20150126621A (ko
Inventor
프랭크 드레허
Original Assignee
앙테이스 에스.아.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 앙테이스 에스.아. filed Critical 앙테이스 에스.아.
Publication of KR20150126621A publication Critical patent/KR20150126621A/ko
Application granted granted Critical
Publication of KR102276326B1 publication Critical patent/KR102276326B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020157025086A 2013-03-13 2014-02-26 피부 회춘을 위한 펩타이드 및 이것을 사용하는 방법 Active KR102276326B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361779601P 2013-03-13 2013-03-13
US61/779,601 2013-03-13
PCT/IB2014/001119 WO2014140890A2 (en) 2013-03-13 2014-02-26 Peptides for skin rejuvenation and methods of using the same

Publications (2)

Publication Number Publication Date
KR20150126621A KR20150126621A (ko) 2015-11-12
KR102276326B1 true KR102276326B1 (ko) 2021-07-13

Family

ID=51263427

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157025086A Active KR102276326B1 (ko) 2013-03-13 2014-02-26 피부 회춘을 위한 펩타이드 및 이것을 사용하는 방법

Country Status (13)

Country Link
US (3) US9375398B2 (enExample)
EP (1) EP2970382B1 (enExample)
JP (1) JP6326601B2 (enExample)
KR (1) KR102276326B1 (enExample)
CN (1) CN105189531B (enExample)
AR (1) AR095276A1 (enExample)
AU (1) AU2014229557B2 (enExample)
CA (1) CA2902938C (enExample)
MX (1) MX360649B (enExample)
RU (1) RU2666533C2 (enExample)
SG (1) SG11201506069RA (enExample)
TW (1) TWI652066B (enExample)
WO (1) WO2014140890A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024106587A1 (ko) * 2022-11-18 2024-05-23 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
WO2024106585A1 (ko) * 2022-11-18 2024-05-23 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014140890A2 (en) 2013-03-13 2014-09-18 Neocutis Sa Peptides for skin rejuvenation and methods of using the same
ES2869024T3 (es) * 2013-11-08 2021-10-22 Hollister Inc Catéteres oleófilos lubricados
US10369091B2 (en) 2013-12-20 2019-08-06 Colgate-Palmolive Company Core shell silica particles and uses thereof as an anti-bacterial agent
US11400032B2 (en) 2013-12-20 2022-08-02 Colgate-Palmolive Company Tooth whitening oral care product with core shell silica particles
US20170303535A1 (en) * 2014-07-31 2017-10-26 Kimberly-Clark Worldwide, Inc. Anti-adherent composition
CA2972015A1 (en) * 2014-12-23 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
JP2016150919A (ja) * 2015-02-18 2016-08-22 ピアス株式会社 塗布用化粧品組成物
MX384467B (es) 2015-04-01 2025-03-14 Kimberly Clark Co Sustrato fibroso para la captura de bacterias gramnegativas.
ITUB20152695A1 (it) * 2015-07-31 2017-01-31 Metis Healthcare S R L Composizione per l'aumento delle secrezioni umorali
CA3002214C (en) 2015-11-03 2022-01-04 Zoetis Services Llc Sol-gel polymer composites and uses thereof
EP3393604A1 (en) 2015-12-24 2018-10-31 Unilever NV Tyrosinase inhibitors
KR101843065B1 (ko) * 2016-01-06 2018-03-28 바이오스펙트럼 주식회사 카노신, 대두 펩타이드 및 천심련 추출물을 포함하는 항노화용 조성물
CN106975523A (zh) * 2016-01-19 2017-07-25 广州绿恒环保科技有限公司 一种新型的具有渗透分解功能光触媒液体
GB201601136D0 (en) 2016-01-21 2016-03-09 Mörgelin Matthias And Abdillahi Suado M Novel polypeptides and medical uses thereof
AU2016389266B2 (en) 2016-01-28 2021-07-01 Kimberly-Clark Worldwide, Inc. Anti-adherent composition against DNA viruses and method of inhibiting the adherence of DNA viruses to a surface
US20170216584A1 (en) * 2016-01-29 2017-08-03 Insung Information Co., Ltd. Sheet mask for iontophoresis and mask assembly using the same
WO2017136600A1 (en) 2016-02-04 2017-08-10 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US10988731B2 (en) * 2016-04-29 2021-04-27 Hope Biosciences, Llc Formulation for storage, transportation, and delivery of protein rich conditioned medium
JP6489487B2 (ja) * 2017-01-20 2019-03-27 富比積生物科技股▲分▼有限公司 テトラペプチド−３ ｇｅｋｇまたはペンタペプチド−３ ｇｅｋｇｆにより変形性関節症を治療するための新規用途
BR112019015800B1 (pt) 2017-02-17 2022-11-22 Imertech Sas Uso de um mineral particulado como agente antipoluição
EP3601316A4 (en) * 2017-03-30 2020-11-18 Escape Therapeutics, Inc. MODULATION BY DECAPEPTIDE 12 OF SIRTUIN GENE EXPRESSION IN EPIDERMAL KERATINOCYTE PROGENITORS
KR101956572B1 (ko) * 2017-04-05 2019-06-24 에이앤펩주식회사 기능성 펩타이드와 콜라겐 발효물을 포함하는 주름 개선용 조성물
EP3606500B1 (en) * 2017-04-07 2023-10-04 Weidmann Holding AG Personal care composition
CN107308101B (zh) * 2017-06-13 2020-06-19 湖南御家化妆品制造有限公司 皮肤紧致组合物及其应用
SG11201907845SA (en) * 2017-06-14 2019-09-27 Biosolution Co Ltd Anti-wrinkle or anti-inflammatory cosmetic composition including substance p
US10258556B2 (en) * 2017-06-19 2019-04-16 Yu-Chun Liu Anti-aging peptide, its composition and method of using the same
CN111182914A (zh) * 2017-08-03 2020-05-19 阿拉斯廷护肤公司 用于改善皮肤松弛和身体轮廓的组合物和方法
IT201700102009A1 (it) * 2017-09-12 2019-03-12 Promoitalia Group Spa Composizione rigenerante e ad azione levigante per il trattamento degli inestetismi della pelle e relativo procedimento di preparazione
JP2020534054A (ja) * 2017-09-18 2020-11-26 インキューブ ラブズ， エルエルシー 化粧剤の経皮送達のためのイオン導入システム、キットおよび方法
CN107857799B (zh) * 2017-11-20 2021-06-04 陕西慧康生物科技有限责任公司 一种四肽-21的液相合成方法
CN116898757A (zh) 2017-12-12 2023-10-20 高露洁-棕榄公司 个人护理组合物
CN108218956A (zh) * 2018-02-23 2018-06-29 广州同隽医药科技有限公司 一种棕榈酰三肽-1的液相合成方法
FR3080532A1 (fr) * 2018-04-26 2019-11-01 Codexial Dermatologie Preparation magistrale dermatologique
EP3787656A1 (en) * 2018-05-04 2021-03-10 The Procter & Gamble Company Compositions and methods for treating vaginal dryness
CN108744024A (zh) * 2018-05-24 2018-11-06 海南芬森医疗器械有限公司 一种复配防疤痕液剂生物敷料及其制备方法
CN108715833B (zh) * 2018-06-01 2021-09-14 天晴干细胞股份有限公司 一种负载血小板裂解液的微球制备方法
CN108888799A (zh) * 2018-06-25 2018-11-27 东莞市联洲知识产权运营管理有限公司 一种具有驱虫性能的增强型复合纤维素医用敷料及其制备方法
KR101924894B1 (ko) * 2018-07-25 2018-12-04 베네브바이오랩 주식회사 소음순 피부 치료용 피부연고
WO2020028694A1 (en) 2018-08-02 2020-02-06 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
US20210187208A1 (en) * 2018-08-23 2021-06-24 The General Hospital Corporation Multifunctional skin patch
KR101965607B1 (ko) * 2018-08-27 2019-04-04 (주)씨앤케이코스메디칼 불연속상 하이드로겔 및 옥수수 전분을 결합제로 포함하는 외력붕해성 고형 클렌저 및 이의 제조 방법
RU2681216C1 (ru) * 2018-09-05 2019-03-05 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ стимуляции регенерации инфицированных ран кожи и мягких тканей с применением пептида Gly-His-Lys-D-Ala
RU2681310C1 (ru) * 2018-09-05 2019-03-06 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ первичной хирургической обработки инфицированных ран кожи и мягких тканей с использованием пептида Gly-His-Lys-D-Ala
US10881882B1 (en) * 2018-12-21 2021-01-05 Btl Medical Technologies S.R.O. Methods and devices for tissue treatment
GB201900728D0 (en) * 2019-01-18 2019-03-06 Univ Birmingham Drug delivery system
CZ308845B6 (cs) * 2019-01-21 2021-07-07 Globetech Innovation S.R.O Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran
KR102203356B1 (ko) * 2019-01-28 2021-01-18 (주)더마펌 피부 노화방지 및 주름개선용 펩타이드 및 이를 포함하는 조성물
US20200237626A1 (en) * 2019-01-28 2020-07-30 Jamrm, Llc Anti-Aging Corrective and Protective Formulation and Methods
EP3930740A4 (en) * 2019-02-25 2022-12-21 Topix Pharmaceuticals, Inc. METHODS, COMPOSITIONS, FILMS FOR THERAPEUTIC SKIN TREATMENTS
CN110257140B (zh) * 2019-06-17 2022-02-15 厦门路辉科技有限公司 一种光学高效芯取磨边液
EP4003485A4 (en) * 2019-07-26 2023-11-22 Photokinetix Holdings Inc. Intravaginal devices, compositions and methods to treat atrophic vaginitis
CN110652484A (zh) * 2019-11-04 2020-01-07 武汉赛锐希斯科技有限公司 一种针对银屑病肤质日常维护的洗发水配方
CN110833514B (zh) * 2019-12-10 2023-05-09 广州赛莱拉干细胞科技股份有限公司 多肽冻干粉及其在制备抗衰老的化妆品中的应用
FR3104977B1 (fr) * 2019-12-20 2023-05-05 Oreal Sérum à base de rétinol
CA3162431A1 (en) * 2020-01-21 2021-07-29 Augustinus Bader Cosmetic formulation for topical administration comprising novel peptides that improve appearance and regeneration of skin
US12077780B2 (en) * 2020-02-14 2024-09-03 Allergan Sales, Llc Conditioned medium from cells cultured under hypoxic conditions and uses thereof
EP3930677A4 (en) * 2020-02-28 2022-11-23 Chanda Zaveri HAIR GROWTH AND SCALP PREPARATIONS
US11590073B2 (en) 2020-06-09 2023-02-28 The Procter & Gamble Company Methods and compositions for reducing the feeling of vaginal dryness
CN111939458A (zh) * 2020-08-25 2020-11-17 四川大学 一种具有超薄柔性背衬层的微针贴片及其制备方法
FR3117014B1 (fr) * 2020-12-07 2024-01-12 Oreal Compositions de soin de la peau incluant l’acide azélaïque et procédés de fabrication d’une composition de soin de la peau
US11464727B2 (en) * 2020-09-29 2022-10-11 Serendipity Technologies Llc Reduced-cost cosmetic formulations that reduce visible signs of ageing
WO2022072663A1 (en) * 2020-10-01 2022-04-07 Emergent Product Development Gaithersburg Inc. Stabilized alkyl nitrite compositions
WO2022140467A1 (en) * 2020-12-21 2022-06-30 Samson Pharma, Llc Topical compositions and methods of treating skin diseases and conditions with such compositions
US20220218584A1 (en) * 2021-01-13 2022-07-14 Allergan Sales, Llc Topical composition and method of use
WO2022157587A1 (en) * 2021-01-23 2022-07-28 Cellix Bio Private Limited A composition comprising lidocaine, l-carnosine and dexpanthenol
CN114469766A (zh) * 2021-02-02 2022-05-13 江苏巴帝恩生物科技有限公司 一种含葡萄糖电解质的保湿及改善肌肤屏障的化妆品组成物
KR102259668B1 (ko) * 2021-03-31 2021-06-01 신승연 프로테오글리칸-함유 크림 화장료 조성물 및 그의 제조방법
CN113376269A (zh) * 2021-05-14 2021-09-10 广东药科大学 一种十一烯酰基苯丙氨酸的含量测定方法
US12208150B2 (en) 2021-05-20 2025-01-28 Shielded, Beauty, LLC Antimicrobial skincare composition
US12171859B2 (en) * 2021-05-25 2024-12-24 Allergan Sales, Llc Topical composition and method of use
CN113368004B (zh) * 2021-06-15 2022-07-29 郑州三铠化妆品有限公司 一种具有抗衰修复功效的多肽组合物及其制备方法与应用
CN113440435B (zh) * 2021-07-07 2022-08-09 珀莱雅化妆品股份有限公司 一种皮肤抗衰老组合物的制备方法
TWI818301B (zh) * 2021-08-20 2023-10-11 富比積生物科技股份有限公司 寡肽於治療牙齦發炎和牙齦萎縮及修復口腔黏膜之用途
WO2023060218A2 (en) * 2021-10-07 2023-04-13 3Helix, Inc. Biologically active collagen hybridizing peptides
WO2023070102A1 (en) * 2021-10-22 2023-04-27 Vaginal Biome Science, Inc. System, product and method for maintaining the vaginal microbiome
US20230130124A1 (en) * 2021-10-25 2023-04-27 Cosmed Pharmaceutical Co., Ltd. Cosmetic microneedle
CN114392393A (zh) * 2021-12-17 2022-04-26 重庆米茜尔医疗美容门诊部有限公司 一种用于皮肤自我修复的皮下注射组合物及其使用方法
CN113956244B (zh) * 2021-12-21 2022-03-29 浙江湃肽生物有限公司深圳分公司 一种用于皮肤复新的肌肽衍生物及其用途
US20230201105A1 (en) * 2021-12-23 2023-06-29 Guangen Xiang Lip Gloss Formulation
CN114369904A (zh) * 2021-12-24 2022-04-19 浙江鹿达科技有限公司 一种抗菌无纺布卫生材料及其制备工艺
KR102792530B1 (ko) * 2021-12-27 2025-04-08 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
KR102792531B1 (ko) * 2021-12-27 2025-04-08 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
KR102792529B1 (ko) * 2021-12-27 2025-04-08 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
KR102788413B1 (ko) * 2021-12-27 2025-03-31 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
CN114452270B (zh) * 2022-01-19 2022-09-27 广东省第二中医院（广东省中医药工程技术研究院） 一种用于治疗骨关节炎的微针贴及其制备方法
CN114344217B (zh) * 2022-01-24 2024-07-09 深圳市琉璃光生物科技有限公司 一种膏状抗氧化护肤品及其生产工艺
CN115024997B (zh) * 2022-05-24 2023-11-17 彭氏(惠州)实业发展有限公司 具有抗皮肤衰老功效的化妆品组合物
CN115161274A (zh) * 2022-06-08 2022-10-11 菲尔生物工程技术有限公司 一种脂肪干细胞提取物的抗皱精华液及其制备方法
CN115261419B (zh) * 2022-07-23 2023-07-21 广州市博之越精细化工有限公司 一种γ-聚谷氨酸钠溶液的制备方法
CN115607467B (zh) * 2022-09-27 2023-05-30 谢志辉生物医药研究院(广州)有限公司 一种含有壬二酸的低刺激性与美白、控油组合物
US20250339361A1 (en) 2022-11-02 2025-11-06 Nutrition & Biosciences USA 4, Inc. Compositions comprising xanthan gum and crystalline alpha-1,3-glucan
KR102796308B1 (ko) * 2022-11-15 2025-04-17 웰펩 주식회사 가려움 유발 사이토카인 제어 효과가 우수한 펩티도미메틱 및 이를 포함하는 화장료 조성물
US12351621B1 (en) 2023-05-03 2025-07-08 Humabiologics, Inc. Composite collagen product and method of making thereof
US12134792B1 (en) 2023-05-03 2024-11-05 Humabiologics, Inc. Process for production of a soluble and insoluble collagen product from mammalian dermis tissue
US12351620B1 (en) 2023-05-03 2025-07-08 Humabiologics, Inc. Process for production of a soluble and insoluble collagen product from mammalian dermis tissue
CN116850081A (zh) * 2023-07-27 2023-10-10 上海君裕生物科技集团有限公司 一种用于敏感肌的修护组合物，冻干面膜及其制备方法
US20250066991A1 (en) * 2023-08-21 2025-02-27 Spora Cayman Holdings Limited Nanoemulsions for internal humectation of mycelium-based textiles
KR102620622B1 (ko) * 2023-09-08 2024-01-04 주식회사 제이포셀 보관 안정성이 향상된 egf를 함유하는 화장료 조성물
WO2025072419A1 (en) 2023-09-29 2025-04-03 Nutrition & Biosciences Usa 1, Llc Crosslinked alpha-glucan derivatives
WO2025072416A1 (en) 2023-09-29 2025-04-03 Nutrition & Biosciences USA 4, Inc. Polysaccharide derivatives
WO2025072417A1 (en) 2023-09-29 2025-04-03 Nutrition & Biosciences USA 4, Inc. Polysaccharide derivatives
US12467171B2 (en) 2023-10-13 2025-11-11 Spora Cayman Holdings Limited Large-scale production of mycelium-based textiles at mushroom farm facilities
WO2025090117A1 (en) * 2023-10-24 2025-05-01 Leuvian, Llc Compositions and methods for treatment of wounds and inflammatory skin conditions
CN117731544B (zh) * 2023-12-19 2024-11-15 广州集妍化妆品科技有限公司 一种含杏仁酸的具有靶向透皮递送功能的淡斑淡印美白增效组合物、其制备方法及其应用
CN117838563A (zh) * 2024-01-09 2024-04-09 杭州悦萱堂化妆品有限公司 一种抗糖复合物及抗糖化妆剂组合物及制备方法
CN117982629B (zh) * 2024-02-19 2024-07-19 北京盛美诺生物技术有限公司 一种iii型小分子胶原蛋白肽在改善面部肤质中的应用
US12409204B1 (en) * 2024-03-08 2025-09-09 Neuvian Ip Holdings, Llc Compositions and methods for hair treatment
WO2025199079A1 (en) 2024-03-20 2025-09-25 Nutrition & Biosciences USA 4, Inc. Esterification of alpha-glucan comprising alpha-1,6 glycosidic linkages
CN118178262A (zh) * 2024-03-30 2024-06-14 上海尊雅实业有限公司 一种美白抗衰组合物及其制备方法、应用
WO2025259983A1 (en) * 2024-06-13 2025-12-18 Colgate-Palmolive Company Skin care compositions
CN118557794B (zh) * 2024-07-31 2025-01-07 杭州科腾生物制品有限公司 一种注射用多肽透明质酸钠复合溶液及其制备方法
CN120938842A (zh) * 2025-03-28 2025-11-14 杭州湃肽生化科技有限公司 一种医美适配型温和强效液体复合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031732A1 (en) * 1996-12-04 2001-10-18 L'oreal S.A. New histidine derivatives, preparation process, and their use as free antiradical agents
US20040132667A1 (en) * 2003-11-17 2004-07-08 Sederma S.A.S Compositions containing mixtures of tetrapeptides and tripeptides
CN1810828A (zh) * 2006-03-03 2006-08-02 华东师范大学 一种脂肪酸－肌肽复合物及其制备方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668365B1 (fr) * 1990-10-25 1994-12-23 Sederma Sa Utilisation en cosmetique des n-acetylpeptides dotes d'une activite biologique.
DE69225631T2 (de) * 1991-02-19 1998-12-17 Cci Corp., Gifu Acylaminosäure-Verbindungen und Verfahren zu ihrer Herstellung
FR2701948B1 (fr) 1993-02-22 1996-07-26 Exsymol Sa Produit de couplage de l'histamine ou l'histamine méthyl-substituée et d'un acide aminé, procédé de préparation et applications thérapeutiques, cosmétologiques et agroalimentaires.
FR2711990B1 (fr) 1993-11-05 1995-12-08 Exsymol Sa Produit pseudodipeptide possédant un groupement imidazole, et applications thérapeutiques, cosmétologiques et agroalimentaires.
WO1998007744A1 (fr) 1996-08-23 1998-02-26 Sederma S.A. Peptides synthetiques et leur utilisation dans les compositions cosmetiques ou dermopharmaceutiques
FR2783169B1 (fr) 1998-09-15 2001-11-02 Sederma Sa Utilisation cosmetique ou dermopharmaceutique de peptides pour la cicatrisation et pour l'amelioration de l'aspect cutane lors du vieillissement naturel ou accelere (heliodermie, pollution)
FR2791684B1 (fr) 1999-03-30 2001-05-11 Sederma Sa Composition cosmetiques ou dermopharmaceutiques contenant le tripeptide n-n-biotinyl-gly-his-lys pour prevenir, reduire ou supprimer la chute des cheveux ainsi que pour favoriser leur repousse
FR2802413B1 (fr) 1999-12-17 2003-10-31 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause
AUPQ515000A0 (en) * 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
FR2805744B1 (fr) 2000-03-03 2006-08-25 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le dipeptide val-trp pour faciliter le drainage lymphatique et diminuer la masse adipeuse
FR2810323B1 (fr) 2000-06-16 2002-09-06 Shiseido Int France Utilisation cosmetique d'un lipopeptide
WO2003032941A2 (de) * 2001-10-13 2003-04-24 Beiersdorf Ag Kosmetische und/oder dermatologische wirkstoffkombination
EP1551399A4 (en) 2002-09-30 2011-01-05 Mark A Babizhayev METHOD FOR THE TOPICAL TREATMENT OF EYE DISEASES AND COMPOSITION AND DEVICE FOR THIS TREATMENT
EP1586332A4 (en) 2003-01-20 2009-11-11 Innovative Vision Products Inc COMBINED USE OF CARNOSINAS INHIBITOR WITH L-CARNOSINES AND COMPOSITION
EP1625150B9 (de) 2003-05-08 2007-06-13 Pentapharm AG Tripeptide und deren derivate für die kosmetische verwendung zur verbesserung der hautstruktur
FR2854897B1 (fr) 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
ES2261036B1 (es) * 2004-10-05 2007-12-16 Lipotec, S.A. Peptidos sinteticos que disminuyen o eliminan las bolsas formadas bajo el contorno inferior de los ojos y su uso en composiciones cosmeticas o dermofarmaceuticas.
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
US20070020220A1 (en) * 2005-04-27 2007-01-25 Procter & Gamble Personal care compositions
PE20070796A1 (es) * 2005-10-24 2007-08-15 Wyeth Corp Metodo de produccion proteica utilizando compuestos anti-senescencia
US20070237735A1 (en) * 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
JP5697869B2 (ja) 2006-06-01 2015-04-08 セラピューティック ペプタイズ，インコーポレーテッド 高分子バイオサーファクタント
PT2409988E (pt) 2006-06-13 2015-10-12 Helix Biomedix Inc Fragmentos peptídicos para induzir síntese de proteínas da matriz extracelular
PL2065029T3 (pl) 2007-11-30 2013-09-30 Evonik Degussa Gmbh Kompozycja do higieny osobistej i kosmetyczna, zawierająca tetrapeptydy z motywami GX1X2G, PX1X2P lub PX1X2K
ES2342754B1 (es) * 2008-10-03 2011-05-11 Lipotec, S.A. Peptidos utiles en el tratamiento y/o cuidado de la piel, mucosas, cuero cabelludo y/o cabello y su uso en composiciones cosmeticas o farmaceuticas.
CA2748375C (en) 2009-01-16 2017-08-01 Neocutis Sa Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
MX2011013060A (es) 2009-06-05 2012-02-28 Aciex Therapeutics Inc Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
FR2946251B1 (fr) * 2009-06-08 2011-05-20 Oreal Composition cosmetique comprenant un derive d'acide salicylique et de la carnosine.
JP2013521300A (ja) 2010-03-03 2013-06-10 ネオキュティス エスアー 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法
FR2975904B1 (fr) * 2011-06-01 2013-08-23 Sederma Sa Nouvelle utilisation topique, cosmetique ou dermopharmaceutique, d'un melange comprenant un tripeptide du type ghk et un tetrapeptide du type gqpr
WO2014140890A2 (en) 2013-03-13 2014-09-18 Neocutis Sa Peptides for skin rejuvenation and methods of using the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031732A1 (en) * 1996-12-04 2001-10-18 L'oreal S.A. New histidine derivatives, preparation process, and their use as free antiradical agents
US20040132667A1 (en) * 2003-11-17 2004-07-08 Sederma S.A.S Compositions containing mixtures of tetrapeptides and tripeptides
CN1810828A (zh) * 2006-03-03 2006-08-02 华东师范大学 一种脂肪酸－肌肽复合物及其制备方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024106587A1 (ko) * 2022-11-18 2024-05-23 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도
WO2024106585A1 (ko) * 2022-11-18 2024-05-23 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도

Also Published As

Publication number Publication date
TW201521758A (zh) 2015-06-16
AU2014229557B2 (en) 2017-12-07
US20200093799A1 (en) 2020-03-26
WO2014140890A3 (en) 2015-04-09
EP2970382A2 (en) 2016-01-20
TWI652066B (zh) 2019-03-01
US20140309173A1 (en) 2014-10-16
CN105189531B (zh) 2020-02-21
RU2015131719A (ru) 2017-04-20
AR095276A1 (es) 2015-09-30
EP2970382B1 (en) 2019-09-25
MX2015011498A (es) 2016-05-31
US9375398B2 (en) 2016-06-28
HK1212363A1 (en) 2016-06-10
US10543195B2 (en) 2020-01-28
US11331305B2 (en) 2022-05-17
KR20150126621A (ko) 2015-11-12
AU2014229557A1 (en) 2015-10-22
CN105189531A (zh) 2015-12-23
JP6326601B2 (ja) 2018-05-23
US20160271109A1 (en) 2016-09-22
CA2902938C (en) 2021-06-01
JP2016516023A (ja) 2016-06-02
MX360649B (es) 2018-11-12
RU2666533C2 (ru) 2018-09-11
WO2014140890A2 (en) 2014-09-18
CA2902938A1 (en) 2014-09-18
SG11201506069RA (en) 2015-09-29

Similar Documents

Publication Publication Date Title
US11331305B2 (en) Peptides for skin rejuvenation and methods of using the same
ES2421262T3 (es) Composición para el cuidado personal y cosmética que contiene tetrapéptidos con las unidades CX1X2G, PX1X2P o PX1X2K
CA2907495C (en) Antioxidant compositions and methods of using the same
ES2381359T3 (es) Composiciones que contienen mezclas de tetrapéptidos y tripéptidos
JP5570978B2 (ja) 新規化合物、化粧品用途および薬用化粧品用途におけるその使用、および該化合物を含む組成物
US9126060B2 (en) Cosmetic use of geranylgeranyl-2-propanol
TWI682782B (zh) 用於皮膚保養之局部投與方法及組合物
KR20200024235A (ko) 피부, 모발, 손톱 및/또는 점막의 치료 및/또는 관리에 유용한 화합물
BR112012017716B1 (pt) Composto, e, composição
US9387235B2 (en) Cosmetic preparations containing PTH fragments
JP2010006844A (ja) インスリン様成長因子−１分泌促進剤
JP4950571B2 (ja) コラーゲン産生促進能を有する組成物
US20250154197A1 (en) Lipolytic peptides
CN115515622A (zh) 用于皮肤状况的衍生自乙酰胆碱酯酶c-末端的多肽
JP6741014B2 (ja) 保湿剤及びこれを含む化粧料
HK1212363B (zh) 用於皮肤复新的肽及其使用方法
KR102084521B1 (ko) 여드름 예방 및 개선용 조성물
HK1146730A (en) Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20150911

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PN2301 Change of applicant

Patent event date: 20180425

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190221

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20200714

Patent event code: PE09021S01D

AMND Amendment
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210109

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210604

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210109

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

Patent event date: 20200714

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

X091 Application refused [patent]
AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20210604

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20210215

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20200819

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20190218

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20210622

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20210617

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20210604

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20210215

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20200819

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20190218

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20210706

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20210707

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20240625

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20250623

Start annual number: 5

End annual number: 5